Skip to main content

Mechanisms of Action of 3-Nitropropionic Acid

Dopamine Overflow and Vulnerability of the Lateral Striatal Artery

  • Chapter
Mitochondrial Inhibitors and Neurodegenerative Disorders

Part of the book series: Contemporary Neuroscience ((CNEURO))

  • 210 Accesses

Abstract

Neurons in the CA1 hippocampus, striatum, or reticular nucleus of the thalamus are most often damaged during brain ischemia. An abundant glutamatergic innervation that drives excitotoxity and the vulnerability of γ-aminobutyric acid-ergic (GABAergic) neurons to such stress has been suggested for the neuronal cell death of these areas (1–4). Intoxication with 3-nitropropionic acid (3-NPA), a mycotoxin that inhibits succinate dehydrogenase irreversibly, leads to high-energy (ATP) deficiency (5–7) and production of free radicals (8, 9), thus results in cellular hypoxia and cellular damage. Systemic intoxication with 3-NPA induces striatum-selective lesions with motor symptoms, reminiscent of Huntington’s disease (10–13). Enhancement of excitotoxicity (5–7) and breakdown of the blood-brain barrier (14–17) have been suggested but mechanisms are not yet well understood. 3-NPA-induced striatal lesions are located in the lateral part of the striatum associated with dysfunction of the blood-brain barrier (17). This suggests that specific mechanisms are operating in this area of the brain. In this chapter, we propose that the dopamine (DA) toxicity due to DA overflow and the vulnerability of the lateral striatal (1STR) artery resulting from damage to endothelial cells and end-feet of astrocytes contribute to development of striatum-selective lesions following systemic 3-NPA intoxication. These characteristics may be major predisposing factors for neurodegenerative diseases, autoimmune diseases, or stroke that often affect the striatum.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623–634.

    Article  PubMed  CAS  Google Scholar 

  2. DiFiglia M. Excitotoxic injury of the neostriatum: a model for Huntington’s disease. Trends Neurosci 1990; 13: 286–289.

    Article  PubMed  CAS  Google Scholar 

  3. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neuro-degenerative disease. Trends Pharmacol Sci 1990; 11: 379–387.

    Article  PubMed  CAS  Google Scholar 

  4. Nishino H, Czurko A, Fukuda A, et al. Pathophysiological process after transient ischemia of the middle cerebral artery in the rat. Brain Res Bull 1994; 35: 51–56.

    Article  PubMed  CAS  Google Scholar 

  5. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness? Ann Neurol 1992; 31: 119–130.

    Article  PubMed  CAS  Google Scholar 

  6. Beal MF, Brouillet E, Jenkins BG, et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993; 13: 4181–4192.

    PubMed  CAS  Google Scholar 

  7. Simpson JR, Isacson O. Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum. Exp Neurol 1993; 121: 57–64.

    Article  PubMed  CAS  Google Scholar 

  8. Beal MF, Ferrante RJ, Henshaw R, et al. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J Neurochem 1995; 65: 919–922.

    Article  PubMed  CAS  Google Scholar 

  9. Schulz JB, Matthews RT, Jenkins BG, et al. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 1995; 15: 8419–8429.

    PubMed  CAS  Google Scholar 

  10. Brouillet M, Hantraye P, Ferrante RT, et al. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 1995; 92: 7105–7109.

    Article  PubMed  CAS  Google Scholar 

  11. Shimano Y, Kumazaki M, Sakurai T, et al. Chronically administered 3-nitropropionic acid produces selective lesions in the striatum and reduces muscle tonus. Obesity Res 1995; 3 (Suppl 5): 779s - 784s.

    CAS  Google Scholar 

  12. Borlongan CV, Koutouzis TK, Freeman TB, et al. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington’s disease. Brain Res 1995; 679: 254–257.

    Article  Google Scholar 

  13. Palfi S, Ferrante RJ, Brouillet E, et al. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington’s disease. J Neurosci 1996; 16: 3019–3025.

    PubMed  CAS  Google Scholar 

  14. Hamilton BF, Gould DH. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol 1987; 72: 286–297.

    Article  PubMed  CAS  Google Scholar 

  15. Hamilton F, Gould DH. Correlation of morphologic brain lesions with physiologic alterations and blood—brain barrier impairment in 3-nitropropionic acid toxicity in rats. Acta Neuropathol 1987; 74: 67–74.

    Article  PubMed  CAS  Google Scholar 

  16. Nishino H, Shimano Y, Kumazaki M, et al. Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood—brain barrier. Neurosci Lett 1995; 186: 161–164.

    Article  PubMed  CAS  Google Scholar 

  17. Nishino H, Kumazaki M, Fukuda A, et al. Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood—brain barrier: involvement of dopamine toxicity. Neurosci Res 1997; 27: 343–355.

    Article  PubMed  CAS  Google Scholar 

  18. He F, Zhang S, Zhang C, et al. Extrapyramidal lesions induced by mildewed sugar cane poisoning. Three case reports. Chin Med J 1987; 67: 395–396.

    CAS  Google Scholar 

  19. Nishino H, Nakajima K, Kumazaki M, et al. Estrogen protects against while testosterone exacerbates vulnerability of the lateral striatal artery to chemical hypoxia by 3-nitropropionic acid. Neurosci Res 1998; 30: 303–312.

    Article  PubMed  CAS  Google Scholar 

  20. Pei G, Ebendal T. Specific lesions in the extrapyramidal system of the rat brain induced by 3-nitropropionic acid (3-NPA). Exp Neurol 1995; 132: 105–115.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Kumazaki, M., Ungsuparkorn, C., Deshpande, S.B., Fukuda, A., Nishino, H. (2000). Mechanisms of Action of 3-Nitropropionic Acid. In: Sanberg, P.R., Nishino, H., Borlongan, C.V. (eds) Mitochondrial Inhibitors and Neurodegenerative Disorders. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-692-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-692-8_11

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9821-9

  • Online ISBN: 978-1-59259-692-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics